OCUL
Ocular Therapeutix, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C-
Company Profile
CEO
Pravin U. Dugel
IPO Date
2014-07-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Ocular Therapeutix, Inc.
CEO
Pravin U. Dugel
IPO Date
2014-07-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 50,092 |
| $0.00 |
| 12 Jun 2026 | Warden Charles M | director | A-Award | Acquired | 14,000 | $0.00 |
| 12 Jun 2026 | Warden Charles M | director | A-Award | Acquired | 44,000 | $8.74 |
| 12 Jun 2026 | Graves Adrienne L | director | A-Award | Acquired | 14,000 | $0.00 |
| 12 Jun 2026 | Graves Adrienne L | director | A-Award | Acquired | 44,000 | $8.74 |
| 12 Jun 2026 | Robins Jason Shand | Chief Financial Officer | A-Award | Acquired | 15,441 | $0.00 |
| 12 Jun 2026 | Robins Jason Shand | Chief Financial Officer | A-Award | Acquired | 14,024 | $8.74 |
| 12 Jun 2026 | Hong Seung Suh | director | A-Award | Acquired | 14,000 | $0.00 |
| 12 Jun 2026 | Hong Seung Suh | director | A-Award | Acquired | 44,000 | $8.74 |